脊髓黑色素细胞瘤的髓内或侵袭性特征:PRISMA系统综述与 pooled 病例分析
两组的复发率分别为26.7%和36.4%,差异无统计学意义(P=0.548)。3例GTR后接受辅助放疗(aRT)的患者未见复发,但该亚组样本量明显不足,结果仅供假设生成。作者认为将此类病变归为良性可能低估其肿瘤学潜能,个体化考虑aRT是合理的。
要点
- 髓内或侵袭性脊髓脑膜黑色素细胞瘤虽被归为良性,但可复发和转移,需按更具侵袭性的方式随访。
- GTR与NTR/STR后的复发率差异无统计学意义(26.7% vs 36.4%,P=0.548)。
- GTR后接受aRT的3例无复发,但样本量明显不足,结果仅供假设生成。
核心结论
- 髓内或侵袭性脊髓脑膜黑色素细胞瘤的“良性” designation 可能低估其肿瘤学潜能。
- 对髓内或侵袭性病变患者,无论切除范围如何,个体化考虑aRT是合理的。
研究设计与样本
- PRISMA系统综述与 pooled 病例分析,纳入2例近期机构病例作为示例。
主要发现
- 56例有复发数据的患者中,GTR后30例中8例(26.7%)复发,NTR/STR后22例中8例(36.4%)复发,组间差异无统计学意义(双侧Fisher精确检验,P=0.548)。
- GTR后接受aRT的3例患者均无复发,而未放疗的27例中8例(29.6%)复发;该亚组样本量明显不足(P=0.545),结果仅供假设生成。
- 9例出现转移或进展,其中1例发生于活检后;8例在初次手术中接受切除者中,2例(25%)为GTR、6例(75%)为STR。
关键数值与推荐
- GTR后复发8/30(26.7%),NTR/STR后复发8/22(36.4%),双侧Fisher精确检验P=0.548。
- GTR后aRT组复发0/3,未放疗组复发8/27(29.6%),双侧Fisher精确检验P=0.545。
- 9例发生转移或进展,其中初次手术切除的8例中GTR 2例(25%)、STR 6例(75%)。
临床怎么用
- 对髓内或侵袭性脊髓脑膜黑色素细胞瘤应提高警惕,不宜仅按良性病变处理。
- 切除范围(GTR或NTR/STR)之外,可个体化讨论aRT,尤其在髓内或侵袭性病例中。
- aRT的获益证据来自样本量明显不足的亚组,决策时应结合个体情况并告知证据局限性。
局限性
- 为系统综述与 pooled 病例分析,非前瞻性对照研究,存在选择与发表偏倚可能。
- aRT亚组仅3例,样本量明显不足,结果仅供假设生成。
- 复发数据仅56例可用,部分亚组例数少,统计效能有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Primary meningeal melanocytomas (MMs) of the spinal cord are rare lesions. Even rarer are intramedullary and invasive variants. These intramedullary lesions may exhibit more aggressive behavior than their "benign" classification appreciates. The role of adjuvant radiotherapy (aRT) in this context remains uncertain. METHODS: This study is a PRISMA-compliant systematic review with a pooled-case analysis, including two recent institutional cases included as illustrative examples. RESULTS: Sixty-three reports were identified of primary intramedullary or invasive MMs. Among 56 patients with available recurrence data, 8 of 30 patients (26.7%) experienced recurrence after gross-total resection (GTR) and in 8 of 22 (36.4%) after near-total or subtotal resection (NTR/STR), with no significant difference between groups (two-sided Fisher's exact, P = 0.548). No recurrence was observed among three patients who received aRT upfront post GTR, compared with 8 of 27 (29.6%) who did not receive radiation (two-sided Fisher's exact, P = 0.545); however, this subgroup was markedly underpowered and should be interpreted as hypothesis-generating only. Nine patients developed metastatic disease or progression, including one post biopsy. Of the eight who underwent resection at index surgery, 2 (25%) had undergone GTR and 6 (75%) STR. CONCLUSIONS: These findings suggest that the designation of MMs as benign lesions may underestimate the oncologic potential of intramedullary or invasive disease. Consideration of aRT on an individualized basis for patients with intramedullary or invasive disease is reasonable, regardless of extent of resection.
引用
- Leon S, Maity A, Gluski J, et al. Intramedullary or invasive characteristics of spinal melanocytomas: a PRISMA compliant systematic review and pooled case analysis. J Neurooncol. 2026. PMID: 42209927. doi:10.1007/s11060-026-05606-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。